Abstract
Background
Cricopharyngeal botulinum toxin (BTX) injection is one of the treatments for neurogenic cricopharyngeal dysfunction (CPD). We conducted this prospective study to investigate the effect and safety of BTX injection for neurogenic CPD with a novel guidance.
Methods
Twenty-one patients with neurogenic CPD whose symptoms did not reduce after conventional swallowing therapy were included in this study. The impact of BTX injection on the swallowing function of the patients was evaluated.
Key Results
After the injection, the Functional Oral Intake Scale (FOIS) score increased in 17 of 21 patients (80.9%), which ranged from 1 to 3 (P < 0.001). Moreover, there was a significant reduction in the UES opening impairment (P < 0.01), UES residual pressure (P < 0.05), duration of UES relaxation, penetration-aspiration scale score (P < 0.05), secretion (P < 0.05), vallecular residue (P < 0.01), and left (P < 0.05) and right (P < 0.05) pyriform sinus residue. With at least 6 months of follow-up, we found that FOIS continued to increase in patients who showed improvement after the injection (i.e., FOIS 5–7 points), while it remained unchanged in patients without improvement after the injection. There were no side effects reported in this study.
Conclusion & Inferences
BTX injection into the cricopharyngeal muscle guided by ultrasound, catheter balloon, and electromyography possibly has a long-lasting effect that can effectively and safely improve the swallowing function of patients with neurogenic CPD.
Similar content being viewed by others
References
Yang H, Yi Y, Han Y. Characteristics of cricopharyngeal dysphagia after ischemic stroke. Ann Rehabil Med. 2018;42:204–12. https://doi.org/10.5535/arm.2018.42.2.204.
Sivarao DV, Goyal RK. Functional anatomy and physiology of the upper esophageal sphincter. Am J Med. 2000;108(4):27–37. https://doi.org/10.1016/s0002-9343(99)00337-x.
Lang IMSR. An overview of the upper esophageal sphincter. Curr Gastroenterol Rep. 2000;2(3):185–90. https://doi.org/10.1007/s11894-000-0059-z.
Allen JE. Cricopharyngeal function or dysfunction: what’s the deal? Curr Opin Otolaryngol Head Neck Surg. 2016;24(6):494–9. https://doi.org/10.1097/MOO.0000000000000307.
Kocdor P, Siegel ER, Tulunay-Ugur OE. Cricopharyngeal dysfunction: a systematic review comparing outcomes of dilatation, botulinum toxin injection, and myotomy. Laryngoscope. 2016;126(1):135–41. https://doi.org/10.1002/lary.25447.
Dou Z, Zu Y, Wen H, Wan G, Jiang L, Hu Y. The effect of different catheter balloon dilatation modes on cricopharyngeal dysfunction in patients with dysphagia. Dysphagia. 2012;27(4):514–20.
Wei X, Yu F, Dai M, Xie C, Wan G, Wang Y, Dou Z. Change in excitability of cortical projection after modified catheter balloon dilatation therapy in brainstem stroke patients with dysphagia: a prospective controlled study. Dysphagia. 2017;32(5):645–56. https://doi.org/10.1007/s00455-017-9810-6.
Kelly EAKI, Jaradeh SS, Merati AL, Blumin JH, Bock JM. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. Ann Otol Rhinol Laryngol. 2013;122(2):100–8. https://doi.org/10.1177/000348941312200205.
Lindgren SEO. Cricopharyngeal myotomy in the treatment of dysphagia. Clin Otolaryngol Allied Sci. 1990;15(3):221–7. https://doi.org/10.1111/j.1365-2273.1990.tb00779.x.
Lebo CPUK, Norris FH Jr. Cricopharyngeal myotomy in amyotrophic lateral sclerosis. Laryngoscope. 1976;86(6):862–8. https://doi.org/10.1288/00005537-197606000-00013.
Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol. 1994;103(1):31–5. https://doi.org/10.1177/000348949410300105.
Huai J, Hou Y, Guan J, Zhang Y, Wang Y, Zhang X, Zhang Y, Yue S. Botulinum toxin A injection using esophageal balloon radiography combined with CT guidance for the treatment of cricopharyngeal dysphagia. Dysphagia. 2020;35(4):630–5. https://doi.org/10.1007/s00455-019-10070-5.
Regan J, Murphy A, Chiang M, McMahon BP, Coughlan T, Walshe M. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders. Cochrane Database Syst Rev. 2014;5:CD009968. https://doi.org/10.1002/14651858.CD009968.pub2.
Haapaniemi JJ, Laurikainen EA, Pulkkinen J, Marttila RJ. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia. 2001;16(3):171–5. https://doi.org/10.1007/s00455-001-0059-7.
Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg. 2000;122(5):691–5. https://doi.org/10.1067/mhn.2000.105997.
Alfonsi E, Restivo DA, Cosentino G, De Icco R, Bertino G, Schindler A, Todisco M, Fresia M, Cortese A, Prunetti P, Ramusino MC, Moglia A, Sandrini G, Tassorelli C. Botulinum toxin is effective in the management of neurogenic dysphagia. Clinical-electrophysiological findings and tips on safety in different neurological disorders. Front Pharmacol. 2017;8:80. https://doi.org/10.3389/fphar.2017.00080.
Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia. 2001;16(3):161–7. https://doi.org/10.1007/s00455-001-0074-8.
Restivo DA, Marchese-Ragona R, Lauria G, Squatrito S, Gullo D, Vigneri R. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Diabetes Care. 2006;29(12):2650–3. https://doi.org/10.2337/dc05-2486.
Terre R, Panades A, Mearin F. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke. Neurogastroenterol Motil. 2013;25(11):896-e702. https://doi.org/10.1111/nmo.12213.
Kim DY, Park CI, Ohn SH, Moon JY, Chang WH, Park SW. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Arch Phys Med Rehabil. 2006;87(10):1346–51. https://doi.org/10.1016/j.apmr.2006.06.018.
Sellin LC. The action of batulinum toxin at the neuromuscular junction. Med Biol. 1981;59(1):11–20.
Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol. 1986;26:427–53. https://doi.org/10.1146/annurev.pa.26.040186.002235.
Restivo DA, Marchese-Ragona R, Patti F, Solaro C, Maimone D, Zappala G, Pavone A. Botulinum toxin improves dysphagia associated with multiple sclerosis. Eur J Neurol. 2011;18(3):486–90. https://doi.org/10.1111/j.1468-1331.2010.03189.x.
Jeong SH, Kim YJ, Kim YJ, Park KD, Kim EJ, Chung JW, Kwon KA, Kim KO, Park DK, Kim JH, Cho JH. Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction. Scand J Gastroenterol. 2018;53(10–11):1201–5. https://doi.org/10.1080/00365521.2018.1506820.
Blitzer A, Brin MF. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg. 1997;116(3):328–30. https://doi.org/10.1016/s0194-5998(97)70267-5.
Krause E, Schirra J, Gurkov R. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage. Dysphagia. 2008;23(4):406–10. https://doi.org/10.1007/s00455-007-9132-1.
Kim MS, Kim GW, Rho YS, Kwon KH, Chung EJ. Office-based electromyography-guided botulinum toxin injection to the cricopharyngeus muscle: optimal patient selection and technique. Ann Otol Rhinol Laryngol. 2017;126(5):349–56. https://doi.org/10.1177/0003489416689469.
Wang YC, Shyu SG, Wu CH, Wang TG. Ultrasound-guided injection of botulinum toxin for cricopharyngeal dysphagia. Am J Phys Med Rehabil. 2018;97(10):e102–3. https://doi.org/10.1097/PHM.0000000000000959.
Wang YC, Wu CH, Shyu SG, Hsiao MY, Wang TG. Ultrasonography-guided botulinum toxin injection to the cricopharyngeus muscle: a case report and technical notes. Med Ultrasonogr. 2019. https://doi.org/10.11152/mu-2097.
Wei P, Xu Y, Zhang Z, Zhang S, Lv Z. Treatment for upper esophageal sphincter dysfunction in a patient with poststroke dysphagia: a case report. Medicine (Baltimore). 2019;98(13):e14988. https://doi.org/10.1097/MD.0000000000014988.
Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86(8):1516–20. https://doi.org/10.1016/j.apmr.2004.11.049.
Martin-Harris B, Brodsky MB, Michel Y, Castell DO, Schleicher M, Sandidge J, Maxwell R, Blair J. MBS measurement tool for swallow impairment-MBSImp: establishing a standard. Dysphagia. 2008;23(4):392–405. https://doi.org/10.1007/s00455-008-9185-9.
Robbins J, Coyle J, Rosenbek J, Roecker E, Wood J. Differentiation of normal and abnormal airway protection during swallowing using the penetration-aspiration scale. Dysphagia. 1999;14(4):228–32. https://doi.org/10.1007/pl00009610.
Murray J, Langmore SE, Ginsberg S, Dostie A. The significance of accumulated oropharyngeal secretions and swallowing frequency in predicting aspiration. Dysphagia. 1996;11(2):99–103. https://doi.org/10.1007/bf00417898.
Neubauer PD, Rademaker AW, Leder SB. The yale pharyngeal residue severity rating scale: an anatomically defined and image-based tool. Dysphagia. 2015;30(5):521–8. https://doi.org/10.1007/s00455-015-9631-4.
McCulloch TM, Hoffman MR, Ciucci MR. High-resolution manometry of pharyngeal swallow pressure events associated with head turn and chin tuck. Ann Otol Rhinol Laryngol. 2010;119(6):369–76. https://doi.org/10.1177/000348941011900602.
Takasaki K, Umeki H, Enatsu K, Tanaka F, Sakihama N, Kumagami H, Takahashi H. Investigation of pharyngeal swallowing function using high-resolution manometry. Laryngoscope. 2008;118(10):1729–32. https://doi.org/10.1097/MLG.0b013e31817dfd02.
Dungan S, Gregorio D, Abrahams T, Harrison B, Abrahams J, Brocato D, Davis C, Espana E, Garcia R, Smith S, Taylor B, Higgins T, Daley L, Carnaby G. Comparative validity of the American Speech-Language-Hearing Association’s national outcomes measurement system, functional oral intake scale, and G-codes to mann assessment of swallowing ability scores for dysphagia. Am J Speech Lang Pathol. 2019;28(2):424–9. https://doi.org/10.1044/2018_ajslp-18-0072.
Costa MM. Videofluoroscopy: the gold standard exam for studying swallowing and its dysfunction. Arq Gastroenterol. 2010;47(4):327–8. https://doi.org/10.1590/s0004-28032010000400001.
Giraldo-Cadavid LF, Leal-Leaño LR, Leon-Basantes GA, Bastidas AR, Garcia R, Ovalle S, Abondano-Garavito JE. Accuracy of endoscopic and videofluoroscopic evaluations of swallowing for oropharyngeal dysphagia. Laryngoscope. 2017;127(9):2002–10. https://doi.org/10.1002/lary.26419.
Hatlebakk JG, Castell JA, Spiegel J, Paoletti V, Katz PO, Castell DO. Dilatation therapy for dysphagia in patients with upper esophageal sphincter dysfunction-manometric and symptomatic response. Dis Esophagus. 1998;11(4):254–9. https://doi.org/10.1093/dote/11.4.254.
Kos MP, David EF, Klinkenberg-Knol EC, Mahieu HF. Long-term results of external upper esophageal sphincter myotomy for oropharyngeal. Dysphagia. 2010;25(3):169–76. https://doi.org/10.1007/s00455-009-9236-x.
Ozgursoy OB, Salassa JR. Manofluorographic and functional outcomes after endoscopic laser cricopharyngeal myotomy for cricopharyngeal bar. Otolaryngol Head Neck Surg. 2010;142(5):735–40. https://doi.org/10.1016/j.otohns.2009.08.020.
Terre R, Valles M, Panades A, Mearin F. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study. Scand J Gastroenterol. 2008;43(11):1296–303. https://doi.org/10.1080/00365520802245403.
Brant CQ, Siqueira ES, Ferrari AP Jr. Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection. Dis Esophagus. 1999;12(1):68–73. https://doi.org/10.1046/j.1442-2050.1999.00015.x.
Liu LW, Tarnopolsky M, Armstrong D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol. 2004;18(6):397–9. https://doi.org/10.1155/2004/360537.
Dodds WJ, Hogan WJ, Lydon SB, Stewart ET, Stef JJ, Arndorfer RC. Quantitation of pharyngeal motor function in normal human subjects. J Appl Physiol. 1975;39(4):692–6. https://doi.org/10.1152/jappl.1975.39.4.692.
Kahrilas PJ. Esophageal motor disorders in terms of high-resolution esophageal pressure topography: what has changed? Am J Gastroenterol. 2010;105(5):981–7. https://doi.org/10.1038/ajg.2010.43.
Sears VW Jr, Castell JA, Castell DO. Radial and longitudinal asymmetry of human pharyngeal pressures during swallowing. Gastroenterology. 1991;101(6):1559–63. https://doi.org/10.1016/0016-5085(91)90392-x.
Kahrilas PJ, Dodds WJ, Dent J, Logemann JA, Shaker R. Upper esophageal sphincter function during deglutition. Gastroenterology. 1988;95(1):52–62. https://doi.org/10.1016/0016-5085(88)90290-9.
Dodds WJ. Physiology of swallowing. Dysphagia. 1989;3(4):171–8. https://doi.org/10.1007/bf02407219.
Castell JA, Castell DO. Modern solid state computerized manometry of the pharyngoesophageal segment. Dysphagia. 1993;8(3):270–5. https://doi.org/10.1007/bf01354550.
Fox M, Hebbard G, Janiak P, Brasseur JG, Ghosh S, Thumshirn M, Fried M, Schwizer W. High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil. 2004;16(5):533–42. https://doi.org/10.1111/j.1365-2982.2004.00539.x.
Ghosh SK, Pandolfino JE, Zhang Q, Jarosz A, Kahrilas PJ. Deglutitive upper esophageal sphincter relaxation: a study of 75 volunteer subjects using solid-state high-resolution manometry. Am J Physiol Gastrointest Liver Physiol. 2006;291(3):G525-531. https://doi.org/10.1152/ajpgi.00081.2006.
Woisard-Bassols V, Alshehri S, Simonetta-Moreau M. The effects of botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness. Eur Arch Otorhinolaryngol. 2013;270(3):805–15. https://doi.org/10.1007/s00405-012-2114-4.
Huai J, Hou Y, Guan J, Zhang Y, Wang Y, Zhang X, Zhang Y, Yue S. Botulinum toxin A injection using esophageal balloon radiography combined with CT guidance for the treatment of cricopharyngeal dysphagia. Dysphagia. 2019. https://doi.org/10.1007/s00455-019-10070-5.
Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol. 2005;26(3):157–62. https://doi.org/10.1016/j.amjoto.2004.11.010.
Cook IJ, Dodds WJ, Dantas RO, Massey B, Kern MK, Lang IM, Brasseur JG, Hogan WJ. Opening mechanisms of the human upper esophageal sphincter. Am J Physiol. 1989;257(5 Pt 1):G748-759. https://doi.org/10.1152/ajpgi.1989.257.5.G748.
Kelly EA, Koszewski IJ, Jaradeh SS, Merati AL, Blumin JH, Bock JM. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. Ann Otol Rhinol Laryngol. 2013;122(2):100–8. https://doi.org/10.1177/000348941312200205.
Alfonsi E, Merlo IM, Ponzio M, Montomoli C, Tassorelli C, Biancardi C, Lozza A, Martignoni E. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment. J Neurol Neurosurg Psychiatry. 2010;81(1):54–60. https://doi.org/10.1136/jnnp.2009.174698.
Acknowledgements
This study was supported by “the Third Affiliated Hospital, Sun Yat-sen University, Clinical Research Program” (No. YHJH201909) for HMW.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
WHM was involved in study concept, drafting, and finalization of manuscript. DZL was involved in study concept and critical review of manuscript. XMS and ZPS were involved in data collection, analysis, and drafting of manuscript. WGF, ADL, SJ, and ZYW were involved in patients’ evaluation and data collection. TZM, LC, and WXM were involved in patient treatment and data collection. All authors do not have any conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xie, M., Zeng, P., Wan, G. et al. The Effect of Combined Guidance of Botulinum Toxin Injection with Ultrasound, Catheter Balloon, and Electromyography on Neurogenic Cricopharyngeal Dysfunction: A Prospective Study. Dysphagia 37, 601–611 (2022). https://doi.org/10.1007/s00455-021-10310-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00455-021-10310-7